A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in Germany
Research output: Contribution to journal › Letter › Contributed › peer-review
Contributors
- Jena University Hospital
- Augusta Hospitals Bochum Hattingen
- University Hospital Münster
- German Center for Lung Research (DZL)
- CAPNETZ STIFTUNG
Abstract
In Germany, the recently approved 20-valent pneumococcal conjugate vaccine had a substantially higher coverage against pneumonia in adults than the 13-valent vaccine, while the coverage gap compared to the 23-valent polysaccharide vaccine was small https://bit.ly/3q4skov
Details
| Original language | English |
|---|---|
| Journal | The European respiratory journal |
| Volume | 59 |
| Issue number | 2 |
| Publication status | Published - Feb 2022 |
| Peer-reviewed | Yes |
External IDs
| PubMedCentral | PMC8812468 |
|---|---|
| ORCID | /0000-0001-6022-6827/work/127318521 |
| Scopus | 85124056875 |
| WOS | 000798166900018 |
Keywords
Subject groups, research areas, subject areas according to Destatis
Sustainable Development Goals
ASJC Scopus subject areas
Keywords
- Germany, Heptavalent Pneumococcal Conjugate Vaccine, Humans, Pneumococcal Infections/prevention & control, Pneumococcal Vaccines, Pneumonia, Pneumococcal/prevention & control, Serogroup, Serotyping, Vaccines, Conjugate, Serotype 3, Conjugate vaccine, Streptococcus pneumoniae, Serotype 8, Serotype-specific urinary antigen detection assay, Disease, Streptococcus-pneumoniae, Burden, Era, Children